Buckingham Strategic Wealth’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $29.9K | Hold |
|
|||||
|
2024
Q1 | $31.6K | Hold |
|
|||||
|
2023
Q4 | $22K | Hold |
|
|||||
|
2023
Q3 | $25.4K | Hold |
|
|||||
|
2023
Q2 | $19.1K | Hold |
|
|||||
|
2023
Q1 | $15K | Hold |
|
|||||
|
2022
Q4 | $15K | Hold |
|
|||||
|
2022
Q3 | $22K | Hold |
|
|||||
|
2022
Q2 | $17K | Hold |
|
|||||
|
2022
Q1 | $21K | Hold |
|
|||||
|
2021
Q4 | $27K | Buy |
|
|||||
|
2021
Q3 | $42K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $51K | Hold |
|
|||||
|
2018
Q4 | $34K | Hold |
|
|||||
|
2018
Q3 | $60K | Hold |
|
|||||
|
2018
Q2 | $64K | Hold |
|
|||||
|
2018
Q1 | $47K | Hold |
|
|||||
|
2017
Q4 | $33K | Sell |
|
|||||
|
2017
Q3 | $107K | Hold |
|
|||||
|
2017
Q2 | $123K | Hold |
|
|||||
|
2017
Q1 | $115K | Buy |
|